Read + Share
Yu X, Li P, Feng H, Kang J, et al. CD58 could be a leukemic marker in patients with relapsed/refractory B-cell acute
lymphoblastic leukemia after multiline therapies. Am J Clin Pathol 2025 Apr 20:aqae166. doi: 10.1093.
PMID: 40253622
|
 |
|
Yu X, Li P, Feng H, Kang J, et al. CD58 could be a leukemic marker in patients with relapsed/refractory B-cell acute
lymphoblastic leukemia after multiline therapies. Am J Clin Pathol 2025 Apr 20:aqae166. doi: 10.1093.
PMID: 40253622
|
|
|
|